1-103571747-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001387437.1(AMY2B):c.145C>A(p.Pro49Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000617 in 1,459,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P49S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001387437.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMY2B | NM_001387437.1 | c.145C>A | p.Pro49Thr | missense_variant | Exon 1 of 10 | ENST00000684275.1 | NP_001374366.1 | |
AMY2B | NM_001386109.1 | c.145C>A | p.Pro49Thr | missense_variant | Exon 3 of 12 | NP_001373038.1 | ||
AMY2B | NM_020978.4 | c.145C>A | p.Pro49Thr | missense_variant | Exon 3 of 12 | NP_066188.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1459652Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726130
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.145C>A (p.P49T) alteration is located in exon 3 (coding exon 1) of the AMY2B gene. This alteration results from a C to A substitution at nucleotide position 145, causing the proline (P) at amino acid position 49 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.